Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2023

Open Access 01-12-2023 | Diabetes | Research

What is the effect of mobile phone text message reminders on medication adherence among adult type 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials

Authors: Abebe Muche Belete, Belete Negese Gemeda, Tadesse Yirga Akalu, Yared Asmare Aynalem, Wondimeneh Shibabaw Shiferaw

Published in: BMC Endocrine Disorders | Issue 1/2023

Login to get access

Abstract

Background

Globally, type 2 diabetes has become increasing. As little is known about the effect of educational intervention on this population, this systematic review and meta-analysis evaluated the effectiveness of mobile phone text message reminders versus usual care to improve medication adherence among type 2 diabetes mellitus patients.

Methods

PubMed, Google Scholar, Cochrane Library, Scopus, and African Journals Online, were searched. A random-effects model was employed to estimate combined effect sizes. Subgroup analyses were employed to investigate possible sources of heterogeneity between studies. The overall certainty of the evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation approach.

Results

A total of 9 trials with 1,121 participants were included in the review. The pooled estimated impact of mobile phone text message reminders on medication adherence was (SMD: 0.36; 95%CI; 0.14, 0.59) compared to usual care groups among patients with type 2 diabetes mellitus. In addition, subgroup analyses revealed greater medication adherence levels in those studies with intervention durations of more than six months and with self-report/refill adherence scale measurement (SMD: 0.21; 95%CI: 0.02, 0.40) and (SMD: 0.45; 95%CI: 0.22, 0.68), respectively.

Conclusion

Mobile phone text messages can potentially lead to improved medication adherence levels in patients with Type 2 diabetes despite heterogeneity across the studies. Therefore, mobile phone text messaging when delivered in addition to usual care, have the potential to produce significant improvements in medication adherence.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fan W. Epidemiology in diabetes mellitus and cardiovascular disease. Cardiovascular endocrinology. 2017;6(1):8.CrossRef Fan W. Epidemiology in diabetes mellitus and cardiovascular disease. Cardiovascular endocrinology. 2017;6(1):8.CrossRef
2.
go back to reference World Health organization GroD, Geneva, 2016. Accessed 30 August 2016. World Health organization GroD, Geneva, 2016. Accessed 30 August 2016.
3.
go back to reference Cho N, Shaw J, Karuranga S, Huang Y, da Rocha FJ, Ohlrogge A, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.CrossRef Cho N, Shaw J, Karuranga S, Huang Y, da Rocha FJ, Ohlrogge A, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.CrossRef
4.
go back to reference International diabetes federation. IDF Diabetes Atlas teB, Belgium: International Diabetes Federation. 2015. . International diabetes federation. IDF Diabetes Atlas teB, Belgium: International Diabetes Federation. 2015. .
5.
go back to reference Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88.CrossRef Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88.CrossRef
6.
go back to reference Meng X-H, Huang Y-X, Rao D-P, Zhang Q, Liu Q. Comparison of three data mining models for predicting diabetes or prediabetes by risk factors. Kaohsiung J Med Sci. 2013;29(2):93–9.CrossRef Meng X-H, Huang Y-X, Rao D-P, Zhang Q, Liu Q. Comparison of three data mining models for predicting diabetes or prediabetes by risk factors. Kaohsiung J Med Sci. 2013;29(2):93–9.CrossRef
7.
go back to reference Organization WH: Global report on diabetes. 2016. Organization WH: Global report on diabetes. 2016.
8.
go back to reference Mohsen IH, Jawad MA, Kadhim AJ, Al-Terehi MN. The oxidative stress state in diabetes mellitus type 2 patients with different medications types. Journal of Chemical Health Risks. 2022;12(3):523–5. Mohsen IH, Jawad MA, Kadhim AJ, Al-Terehi MN. The oxidative stress state in diabetes mellitus type 2 patients with different medications types. Journal of Chemical Health Risks. 2022;12(3):523–5.
9.
go back to reference Alkomos MF, Mendez D, Mazzei-Pifano D, Shafeek F, Rodriguez C, Ali F, Banks C, Melki G, Michael P. Patients’ reasons for missing scheduled clinic appointments and their solutions at a major urban-based academic medical center. Journal of community hospital internal medicine perspectives. 2020;10(5):426–30.CrossRef Alkomos MF, Mendez D, Mazzei-Pifano D, Shafeek F, Rodriguez C, Ali F, Banks C, Melki G, Michael P. Patients’ reasons for missing scheduled clinic appointments and their solutions at a major urban-based academic medical center. Journal of community hospital internal medicine perspectives. 2020;10(5):426–30.CrossRef
10.
go back to reference Meece J. Improving medication adherence among patients with type 2 diabetes. J Pharm Pract. 2014;27(2):187–94.CrossRef Meece J. Improving medication adherence among patients with type 2 diabetes. J Pharm Pract. 2014;27(2):187–94.CrossRef
11.
go back to reference Kesavadev J, Saboo B, Shankar A, Krishnan G, Jothydev S. Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy. Indian journal of endocrinology and metabolism. 2015;19(6):764–9.CrossRef Kesavadev J, Saboo B, Shankar A, Krishnan G, Jothydev S. Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy. Indian journal of endocrinology and metabolism. 2015;19(6):764–9.CrossRef
12.
go back to reference Leong KC, Chen WS, Leong KW, Mastura I, Mimi O, Sheikh MA, Zailinawati AH, Ng CJ, Phua KL, Teng CL. The use of text messaging to improve attendance in primary care: a randomized controlled trial. Fam Pract. 2006;23(6):699–705.CrossRef Leong KC, Chen WS, Leong KW, Mastura I, Mimi O, Sheikh MA, Zailinawati AH, Ng CJ, Phua KL, Teng CL. The use of text messaging to improve attendance in primary care: a randomized controlled trial. Fam Pract. 2006;23(6):699–705.CrossRef
13.
go back to reference Wald DS, Bestwick JP, Raiman L, Brendell R, Wald NJ. Randomised trial of text messaging on adherence to cardiovascular preventive treatment (INTERACT trial). PLoS ONE. 2014;9(12): e114268.CrossRef Wald DS, Bestwick JP, Raiman L, Brendell R, Wald NJ. Randomised trial of text messaging on adherence to cardiovascular preventive treatment (INTERACT trial). PLoS ONE. 2014;9(12): e114268.CrossRef
14.
go back to reference Gautier J-F, Boitard C, Michiels Y, Raymond G, Vergez G, Guedon G. Impact of personalized text messages from pharmacists on medication adherence in type 2 diabetes in France: A real-world, randomized, comparative study. Patient Educ Couns. 2021;104(9):2250–8.CrossRef Gautier J-F, Boitard C, Michiels Y, Raymond G, Vergez G, Guedon G. Impact of personalized text messages from pharmacists on medication adherence in type 2 diabetes in France: A real-world, randomized, comparative study. Patient Educ Couns. 2021;104(9):2250–8.CrossRef
15.
go back to reference Vervloet M, van Dijk L, Santen-Reestman J, Van Vlijmen B, Van Wingerden P, Bouvy ML, de Bakker DH. SMS reminders improve adherence to oral medication in type 2 diabetes patients who are real time electronically monitored. Int J Med Informatics. 2012;81(9):594–604.CrossRef Vervloet M, van Dijk L, Santen-Reestman J, Van Vlijmen B, Van Wingerden P, Bouvy ML, de Bakker DH. SMS reminders improve adherence to oral medication in type 2 diabetes patients who are real time electronically monitored. Int J Med Informatics. 2012;81(9):594–604.CrossRef
16.
go back to reference Vervloet M, Van Dijk L, De Bakker D, Souverein P, Santen-Reestman J, Van Vlijmen B, van Aarle M, van Der Hoek L, Bouvy M. Short-and long-term effects of real-time medication monitoring with short message service (SMS) reminders for missed doses on the refill adherence of people with Type 2 diabetes: evidence from a randomized controlled trial. Diabet Med. 2014;31(7):821–8.CrossRef Vervloet M, Van Dijk L, De Bakker D, Souverein P, Santen-Reestman J, Van Vlijmen B, van Aarle M, van Der Hoek L, Bouvy M. Short-and long-term effects of real-time medication monitoring with short message service (SMS) reminders for missed doses on the refill adherence of people with Type 2 diabetes: evidence from a randomized controlled trial. Diabet Med. 2014;31(7):821–8.CrossRef
17.
go back to reference Arora S, Peters AL, Burner E, Lam CN, Menchine M: Trial to examine text message–based mHealth in emergency department patients with diabetes (TExT-MED): A randomized controlled trial. Annals of emergency medicine 2014, 63(6):745–754. e746. Arora S, Peters AL, Burner E, Lam CN, Menchine M: Trial to examine text message–based mHealth in emergency department patients with diabetes (TExT-MED): A randomized controlled trial. Annals of emergency medicine 2014, 63(6):745–754. e746.
19.
go back to reference Moher DSL, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1–9.CrossRef Moher DSL, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1–9.CrossRef
20.
go back to reference McGowan JSM, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40–6.CrossRef McGowan JSM, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40–6.CrossRef
21.
go back to reference Sterne JA SJ, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM: RoB 2: a revised tool for assessing risk of bias in randomised trials. bmj 2019, 366. Sterne JA SJ, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM: RoB 2: a revised tool for assessing risk of bias in randomised trials. bmj 2019, 366.
22.
go back to reference Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.CrossRef Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.CrossRef
23.
go back to reference Guyatt G OA, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. Journal of clinical epidemiology. 2011 Apr 1;64(4):383–94. Guyatt G OA, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. Journal of clinical epidemiology. 2011 Apr 1;64(4):383–94.
25.
go back to reference Abaza H, Marschollek M. SMS education for the promotion of diabetes self-management in low & middle income countries: a pilot randomized controlled trial in Egypt. BMC Public Health. 2017;17(1):1–19.CrossRef Abaza H, Marschollek M. SMS education for the promotion of diabetes self-management in low & middle income countries: a pilot randomized controlled trial in Egypt. BMC Public Health. 2017;17(1):1–19.CrossRef
26.
go back to reference Gautier J-F, Boitard C, Michiels Y, Raymond G, Vergez G, Guedon G: Impact of personalized text messages from pharmacists on medication adherence in type 2 diabetes in France: A real-world, randomized, comparative study. Patient Education and Counseling 2021. Gautier J-F, Boitard C, Michiels Y, Raymond G, Vergez G, Guedon G: Impact of personalized text messages from pharmacists on medication adherence in type 2 diabetes in France: A real-world, randomized, comparative study. Patient Education and Counseling 2021.
27.
go back to reference Kleinman NJ, Shah A, Shah S, Phatak S, Viswanathan V. Improved medication adherence and frequency of blood glucose self-testing using an m-Health platform versus usual care in a multisite randomized clinical trial among people with type 2 diabetes in India. Telemedicine and e-Health. 2017;23(9):733–40.CrossRef Kleinman NJ, Shah A, Shah S, Phatak S, Viswanathan V. Improved medication adherence and frequency of blood glucose self-testing using an m-Health platform versus usual care in a multisite randomized clinical trial among people with type 2 diabetes in India. Telemedicine and e-Health. 2017;23(9):733–40.CrossRef
28.
go back to reference Owolabi EO, Ter Goon D, Ajayi AI: Impact of mobile phone text messaging intervention on adherence among patients with diabetes in a rural setting: a randomized controlled trial. Medicine 2020, 99(12). Owolabi EO, Ter Goon D, Ajayi AI: Impact of mobile phone text messaging intervention on adherence among patients with diabetes in a rural setting: a randomized controlled trial. Medicine 2020, 99(12).
29.
go back to reference Sugita H, Shinohara R, Yokomichi H, Suzuki K, Yamagata Z. Effect of text messages to improve health literacy on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled pilot trial. Nagoya J Med Sci. 2017;79(3):313. Sugita H, Shinohara R, Yokomichi H, Suzuki K, Yamagata Z. Effect of text messages to improve health literacy on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled pilot trial. Nagoya J Med Sci. 2017;79(3):313.
30.
go back to reference Adikusuma W, Qiyaam N. The effect of education through short message service (SMS) messages on diabetic patients adherence. Sci Pharm. 2017;85(2):23.CrossRef Adikusuma W, Qiyaam N. The effect of education through short message service (SMS) messages on diabetic patients adherence. Sci Pharm. 2017;85(2):23.CrossRef
31.
go back to reference Zhuang Q, Chen F, Wang T. Effectiveness of short message service intervention to improve glycated hemoglobin control and medication adherence in type-2 diabetes: A meta-analysis of prospective studies. Prim Care Diabetes. 2020;14(4):356–63.CrossRef Zhuang Q, Chen F, Wang T. Effectiveness of short message service intervention to improve glycated hemoglobin control and medication adherence in type-2 diabetes: A meta-analysis of prospective studies. Prim Care Diabetes. 2020;14(4):356–63.CrossRef
32.
go back to reference Nkhoma DE, Soko CJ, Banda KJ, Greenfield D, Li Y-CJ, Iqbal U: Impact of DSMES app interventions on medication adherence in type 2 diabetes mellitus: systematic review and meta-analysis. BMJ health & care informatics 2021, 28(1). Nkhoma DE, Soko CJ, Banda KJ, Greenfield D, Li Y-CJ, Iqbal U: Impact of DSMES app interventions on medication adherence in type 2 diabetes mellitus: systematic review and meta-analysis. BMJ health & care informatics 2021, 28(1).
33.
go back to reference Farmer A, McSharry J, Rowbotham S, McGowan L, Ricci-Cabello I, French D. Effects of interventions promoting monitoring of medication use and brief messaging on medication adherence for people with Type 2 diabetes: a systematic review of randomized trials. Diabet Med. 2016;33(5):565–79.CrossRef Farmer A, McSharry J, Rowbotham S, McGowan L, Ricci-Cabello I, French D. Effects of interventions promoting monitoring of medication use and brief messaging on medication adherence for people with Type 2 diabetes: a systematic review of randomized trials. Diabet Med. 2016;33(5):565–79.CrossRef
34.
go back to reference Palmer MJ, Machiyama K, Woodd S, Gubijev A, Barnard S, Russell S, Perel P, Free C: Mobile phone‐based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults. Cochrane Database of Systematic Reviews 2021(3). Palmer MJ, Machiyama K, Woodd S, Gubijev A, Barnard S, Russell S, Perel P, Free C: Mobile phone‐based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults. Cochrane Database of Systematic Reviews 2021(3).
35.
go back to reference Lin LKSY, Heng BH, Chew DE, Chong PN. Medication adherence and glycemic control among newly diagnosed diabetes patients. BMJ Open Diabetes Res Care. 2017;5(1): e000429.CrossRef Lin LKSY, Heng BH, Chew DE, Chong PN. Medication adherence and glycemic control among newly diagnosed diabetes patients. BMJ Open Diabetes Res Care. 2017;5(1): e000429.CrossRef
36.
go back to reference Osei-Yeboah J, Lokpo SY, Owiredu WK, Johnson BB, Orish VN, Botchway F, Ussher FA, Avorkliyah R: Medication Adherence and its Association with Glycaemic Control, Blood Pressure Control, Glycosuria and Proteinuria Among People Living With Diabetes (PLWD) in the Ho Municipality, Ghana. The Open Public Health Journal 2018, 11(1). Osei-Yeboah J, Lokpo SY, Owiredu WK, Johnson BB, Orish VN, Botchway F, Ussher FA, Avorkliyah R: Medication Adherence and its Association with Glycaemic Control, Blood Pressure Control, Glycosuria and Proteinuria Among People Living With Diabetes (PLWD) in the Ho Municipality, Ghana. The Open Public Health Journal 2018, 11(1).
37.
go back to reference Thakkar J, Kurup R, Laba T-L, Santo K, Thiagalingam A, Rodgers A, Woodward M, Redfern J, Chow CK. Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis. JAMA Intern Med. 2016;176(3):340–9.CrossRef Thakkar J, Kurup R, Laba T-L, Santo K, Thiagalingam A, Rodgers A, Woodward M, Redfern J, Chow CK. Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis. JAMA Intern Med. 2016;176(3):340–9.CrossRef
Metadata
Title
What is the effect of mobile phone text message reminders on medication adherence among adult type 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials
Authors
Abebe Muche Belete
Belete Negese Gemeda
Tadesse Yirga Akalu
Yared Asmare Aynalem
Wondimeneh Shibabaw Shiferaw
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2023
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-023-01268-8

Other articles of this Issue 1/2023

BMC Endocrine Disorders 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine